Lymphocyte antigen 75

BE0010744ProteinHumansLY75

Acts as an endocytic receptor to direct captured antigens from the extracellular space to a specialized antigen-processing compartment (By similarity). It is acted on by 2 drugs in DrugBank.

Gene name
LY75
UniProtKB entry
O60449Swiss-Prot
Cellular location
Membrane
Residues / weight
1,722 residues · 198,310 Da
Also known as
C-type lectin domain family 13 member B · CD205 · CLEC13B · DEC-205 · gp200-MR6

Resolves to

Protein
UniProtO60449UniProt nameLY75_HUMAN
Gene
HGNCHGNC:6729NCBI Gene4065GeneCardsLY75
Pharmacology
KEGGhsa:4065
Structure
PDB7JPTPDB7JPUPDB8HBC
Drugs

What you can answer from here — as of October 31, 2023

2DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
3Clinical trialsTrials of drugs acting on it, by phase and status
Sign in
2GO termsFunction, process and component, as structured annotations
Sign in
3Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
7+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on Lymphocyte antigen 75, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In